Next Generation Protein Sequencing and Characterisation
De novo protein sequencing has become an excellent tool for commercial and non-commercial antibody research and development.
View our on-demand webinar, presented by Rapid Novor on May 15, 2024 and hosted by Krishgen, for exclusive insights on Next Generation Protein Sequencing and Characterisation.
How Next Generation Protein Sequencing (NGPS) works
Applications of NGPS to aid engineering and recombinant production of antibodies
How REmAb® De Novo Protein Sequencing Works
Engage in thought-provoking discussions with our experts during the interactive Q&A session
Speaker Monique Seymour, MSc
Senior Scientific Sales Executive
At Rapid Novor, Monique has worked collaboratively with hundreds of scientists in both therapeutic and diagnostic fields globally to understand their goals and apply her proteomics knowledge in tandem with Rapid Novor’s REmAb® service to speed up discovery. When not at a desk or a lab, you can find her globetrotting across Europe and Asia.